Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | LTA4H | P09960 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.32 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.32 |
| ▸ | ITGAL | P20701 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10054032 | 0.75 | USP2 (0.37) | CA2CA12CA9ALDH1A1MAOB | |
| SCHEMBL3626503 | 0.74 | CA2 (0.36) | CA2ABCG2ITGB2ICAM1ITGAL | |
| SCHEMBL11549002 | 0.73 | CA2 (0.37) | CA2NPC1L3MBTL1ALDH1A1 | |
| SCHEMBL21624268 | 0.73 | LMNA (0.35) | CA2LTA4HALDH1A1MAPTMAOB | |
| SCHEMBL7709636 | 0.71 | PTPN1 (0.33) | — | |
| SCHEMBL7709944 | 0.71 | CYP3A4 (0.33) | ALDH1A1 | |
| SCHEMBL11034100 | 0.70 | POLB (0.46) | CA2NPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL7988202 | 0.69 | ALDH1A1 (0.46) | RAB9AALDH1A1 | |
| SCHEMBL312107 | 0.69 | ABCG2 (0.36) | CA2ABCG2ITGB2ICAM1ITGAL | |
| SCHEMBL353825 | 0.69 | PARP1 (0.40) | CA2PARP1ABCG2ITGB2ICAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630504-B2 | Phenethylamine derivatives, compositions, and methods of use | CYBIN IRL LIMITED (IE) | 2026-05-19 | — | — | US | disclosed |
| US-12535735-B2 | Modified thioxanthone photoinitiators | LINTFIELD LIMITED (GB) | 2026-01-27 | — | — | US | disclosed |
| US-12398152-B2 | Thioxanthone derivatives, composition comprising the same and pattern forming method comprising said composition | LINTFIELD LIMITED (GB) | 2025-08-26 | — | — | US | disclosed |
| US-20250145566-A1 | PHENETHYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE | CYBIN IRL LIMITED (IE) | 2025-05-08 | — | — | US | disclosed |
| US-20240317704-A1 | PHENETHYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE | CYBIN IRL LIMITED (IE) | 2024-09-26 | — | — | US | disclosed |
| US-20230322742-A1 | ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES | AGILENT TECHNOLOGIES, INC. | 2023-10-12 | — | — | US | disclosed |
| US-20230322742-A1 | ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES | AGILENT TECHNOLOGIES, INC. | 2023-10-12 | — | — | US | disclosed |
| US-20230082557-A1 | Modified Thioxanthone Photoinitiators | LINTFIELD LIMITED (GB) | 2023-03-16 | — | — | US | disclosed |
| US-11548876-B2 | Orthoester compositions for affinity purification of oligonucleotides | AGILENT TECHNOLOGIES, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| EP-4090656-A1 | MODIFIED THIOXANTHONE PHOTOINITIATORS | Lintfield Limited (GB) | 2022-11-23 | — | — | EP | disclosed |
| US-20210277017-A1 | Thioxanthone Derivatives, Composition Comprising the Same and Pattern Forming Method Comprising Said Composition | LINTFIELD LIMITED (GB) | 2021-09-09 | — | — | US | disclosed |
| WO-2021144582-A1 | MODIFIED THIOXANTHONE PHOTOINITIATORS | LINTFIELD LIMITED (GB) | 2021-07-22 | — | — | WO | disclosed |
| EP-3824349-A1 | THIOXANTHONE DERIVATIVES, COMPOSITION COMPRISING THE SAME AND PATTERN FORMING METHOD COMPRISING SAID COMPOSITION | Lintfield Limited (GB) | 2021-05-26 | — | — | EP | disclosed |
| US-20200190129-A1 | ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES | AGILENT TECHNOLOGIES, INC. | 2020-06-18 | — | — | US | disclosed |
| US-20200181124-A1 | ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES | AGILENT TECHNOLOGIES, INC. | 2020-06-11 | — | — | US | disclosed |
| WO-2020016389-A1 | THIOXANTHONE DERIVATIVES, COMPOSITION COMPRISING THE SAME AND PATTERN FORMING METHOD COMPRISING SAID COMPOSITION | LINTFIELD LIMITED (GB) | 2020-01-23 | — | — | WO | disclosed |
| US-20120161089-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2012-06-28 | — | — | US | disclosed |
| US-20120161089-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2012-06-28 | — | — | US | disclosed |
| EP-1463726-A2 | AROMATIC THIOETHER LIVER X-RECEPTOR MODULATORS | Pharmacia Corporation (US) | 2004-10-06 | — | — | EP | disclosed |
| WO-2003059874-A2 | AROMATIC THIOETHER LIVER X-RECEPTOR MODULATORS | PHARMACIA CORPORATION (US) | 2003-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240317704-A1 | PHENETHYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE | HTR2C, HTR2A, PNMT | CA2 4694/4885CA4 4775/4885LTA4H 960/4885 |
| US-20200190129-A1 | ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES | RNGTT, OSBPL8, DCLRE1B | CA2 4500/4885CA4 3077/4885LTA4H 3843/4885 |
| US-20230082557-A1 | Modified Thioxanthone Photoinitiators | TPMT, PPOX, TST | CA2 2021/4885CA4 884/4885LTA4H 23/4885 |
| US-12630504-B2 | Phenethylamine derivatives, compositions, and methods of use | HTR2C, HTR1A, HTR2A | CA2 3591/4885CA4 4656/4885LTA4H 2119/4885 |
| US-12398152-B2 | Thioxanthone derivatives, composition comprising the same and pattern forming method comprising said composition | TPMT, TST, PPOX | CA2 3199/4885CA4 998/4885LTA4H 23/4885 |
| US-20200181124-A1 | ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES | RNGTT, OSBPL8, DCLRE1B | CA2 4500/4885CA4 3077/4885LTA4H 3843/4885 |
| US-12535735-B2 | Modified thioxanthone photoinitiators | FTO, UGT1A6, TPMT | CA2 2247/4885CA4 1090/4885LTA4H 341/4885 |
| US-11548876-B2 | Orthoester compositions for affinity purification of oligonucleotides | RNGTT, OSBPL8, DCLRE1B | CA2 4500/4885CA4 3077/4885LTA4H 3843/4885 |
| US-20230322742-A1 | ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES | RNGTT, OSBPL8, DCLRE1B | CA2 4500/4885CA4 3077/4885LTA4H 3843/4885 |
| US-20120161089-A1 | CHROMENE COMPOUND | CYP8B1, HSD3B2, CYP17A1 | CA2 2725/4885CA4 3696/4885LTA4H 4307/4885 |
| US-20250145566-A1 | PHENETHYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE | PNMT, HTR7, HTR2C | CA2 4775/4885CA4 4705/4885LTA4H 779/4885 |
| US-20210277017-A1 | Thioxanthone Derivatives, Composition Comprising the Same and Pattern Forming Method Comprising Said Composition | TPMT, TST, PPOX | CA2 3199/4885CA4 998/4885LTA4H 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.